Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug.

Source:http://linkedlifedata.com/resource/pubmed/id/19372554

Download in:

View as

General Info

PMID
19372554